Company / Operating Cash Flow
Bioventus Inc. Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$74.7M
FY2025
5-year range
-$13.5M / $74.7M
FY2021-FY2025
Trend
+92.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has increased for 3 consecutive years, from -$14M in FY2022 to $75M in FY2025.
Based on SEC 10-K filings.
$75M in FY2025.
Improved from $23M to $75M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 92.5% year-over-year.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.7M | +92.5% |
| FY2024 | $38.8M | +68.7% |
| FY2023 | $23.0M | +269.8% |
| FY2022 | -$13.5M | -133.2% |
| FY2021 | $40.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026